A Phase 2 Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma Following Systemic Therapy
Phase of Trial: Phase II
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Afatinib (Primary)
- Indications Penile cancer; Squamous cell cancer
- Focus Therapeutic Use
- 12 Nov 2015 Planned primary completion date changed from 1 Sep 2018 to 1 Oct 2018, as reported by ClinicalTrials.gov.
- 12 Nov 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 07 Sep 2015 New trial record